KRAS and ovarian carcinoma: Because the KRAS-variant predicts poor ovarian cancer specific survival in uninformative patients [14], we investigated the association of the prevalence of the KRAS-variant and time between ovarian cancer diagnosis and study recruitment for uninformative patients with available information (n = 82).